Lisette Koeneman

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics

Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiß et al. · JAMA Network Open · 2022 · 32 citations · Full text

Pharmacy, Geriatric Medicine, Pharmacotherapy +17

Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

Avraham Karasik, Stefanie Lanzinger, Elise Tan et al. · Diabetes & Metabolism · 2023 · 26 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiß et al. · Cardiovascular Diabetology · 2024 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effectiveness and safety of empagliflozin: final results from the EMPRISE study

Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiß et al. · Diabetologia · 2024 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity

Milton Packer, Michael R. Zile, Christopher M. Kramer et al. · Journal of the American College of Cardiology · 2025 · 17 citations

Medicine, Cardiology, Internal Medicine +12